Provid Pharmaceuticals - Crunchbase Company Profile & Funding

Q: Who invested in Provid Pharmaceuticals?

Provid Pharmaceuticals is funded by NJEDA.

Overview

Provid Pharmaceuticals

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Provid Pharmaceuticals

CB Rank

714157

Provid Pharmaceuticals is a drug discovery company.

Founded

obfuscation

Private

Venture - Series Unknown

Monmouth Junction, New Jersey, United States

51-100

www.provid.com

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Key People

Charles Cook: Co-founder
Gary Olson: President & CEO

Details

Operating Status

Active

Company Type

For Profit

Founders

Amos B. Smith III, Charles Cook, Christopher Self, Gary Olson, Ralph Hirschmann

About the Company

Provid was co-founded in 2001 by Drs. Gary Olson, Christopher Self, and Charles Cook, together with Profs. Amos B. Smith, III and Ralph Hirschmann of the University of Pennsylvania. The team has exceptional talent in synthetic and medicinal chemistry and includes world leaders in peptide and peptide mimetics technology and in structure-based drug

design. Their experience makes Provid the premier drug discovery company for early stage research and translational drug development.

Phone Number

(732) 565-1101

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

PV-3212

A small molecule inhibitor that selectively blocks antigen binding to MHC class II molecule DR15, preventing activation of autoreactive T cells involved in autoimmune diseases.

MHC Class II DR15 Inhibition Platform

A therapeutic approach targeting disease-associated MHC class II molecules, especially DR15, to block antigen binding and prevent autoimmune T cell activation.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Provid Pharmaceuticals	1	obfuscated obfuscation	NJEDA	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Provid Pharmaceuticals	1	obfuscated obfuscation	NJEDA	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Provid Pharmaceuticals	1	obfuscated obfuscation	NJEDA	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Provid Pharmaceuticals	1	obfuscated obfuscation	NJEDA	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Provid Pharmaceuticals	1	obfuscated obfuscation	NJEDA	Venture - Series Unknown

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Provid Pharmaceuticals	1	obfuscated obfuscation	NJEDA	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Provid Pharmaceuticals	1	obfuscated obfuscation	NJEDA	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Provid Pharmaceuticals	1	obfuscated obfuscation	NJEDA	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Provid Pharmaceuticals	1	obfuscated obfuscation	NJEDA	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Provid Pharmaceuticals	1	obfuscated obfuscation	NJEDA	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
NJEDA	Yes	Venture Round - Provid Pharmaceuticals	—
NJEDA	Yes	Venture Round - Provid Pharmaceuticals	—
NJEDA	Yes	Venture Round - Provid Pharmaceuticals	—
NJEDA	Yes	Venture Round - Provid Pharmaceuticals	—
NJEDA	Yes	Venture Round - Provid Pharmaceuticals	—